Skip to main content
PFSA
NASDAQ Industrial Applications And Services

Profusa Finalizes 1-for-75 Reverse Stock Split to Take Effect February 9th, Reducing Shares to 1.2 Million

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.081
Mkt Cap
$7.44M
52W Low
$0.065
52W High
$13
52W Position info
25% above low
Off High info
99% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

PFSA sits 25% above its 52-week low of $0.065 on light trading volume (0.2× avg).

Summary

Profusa, Inc. has finalized a 1-for-75 reverse stock split, effective February 9, 2026, to consolidate its common stock and maintain Nasdaq listing compliance.


Key Events · Corporate Governance and Compliance · PFSA

  • Reverse Stock Split Finalized

    The company's CEO, under authority granted by the board, approved a 1-for-75 reverse stock split, effective 12:01 a.m. Eastern Time on February 9, 2026.

  • Significant Share Reduction

    The reverse split will reduce the number of outstanding common shares from approximately 92.4 million to about 1.2 million, while authorized shares remain at 601 million.

  • Nasdaq Listing Compliance

    The action is intended to help the company meet Nasdaq Capital Market's minimum bid price requirements, with post-split trading commencing February 9, 2026, under the existing ticker symbol PFSA.

  • Fractional Share Treatment

    No fractional shares will be issued; stockholders entitled to fractional shares will receive a cash payment based on the closing price on the effective date.


Analysis · PFSA · Industrial Applications And Services

This 8-K filing confirms the specific terms and effective date of the reverse stock split, following the stockholder approval on February 2, 2026, for a range of ratios. The chosen 1-for-75 ratio is aggressive, significantly reducing outstanding shares and indicating a critical effort to meet Nasdaq's minimum bid price requirements and avoid delisting. For a micro-cap company like Profusa, a reverse split is often a necessary but negative signal, highlighting underlying financial challenges and potentially paving the way for further dilutive capital raises, as suggested by the recent S-1 filing on February 4, 2026, which included an equity line.

How filings like this one have moved

In the 30 days to Aug 23, 2026, 43.4% of the 1019 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.13%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PFSA was trading at $0.08 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $7.4M. The 52-week trading range was $0.07 to $13.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PFSA - Latest Insights

PFSA
Aug 21, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.41
Real-time Price: $5.47 info
Change: +$0.0562 (+1%) info
Market Cap: $3.307M info
PFSA
Aug 20, 2026, 8:32 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $13.13
Real-time Price: $5.47 info
Change: -$7.66 (-58%) info
Market Cap: $3.307M info
PFSA
Aug 20, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $13.10
Real-time Price: $5.47 info
Change: -$7.64 (-58%) info
Market Cap: $3.307M info
PFSA
Aug 19, 2026, 8:15 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $13.10
Real-time Price: $5.47 info
Change: -$7.63 (-58%) info
Market Cap: $3.307M info
PFSA
Aug 19, 2026, 8:14 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $13.10
Real-time Price: $5.47 info
Change: -$7.63 (-58%) info
Market Cap: $3.307M info